Jiang Lv (Peng Li)

Years Active: 2019-2020
Publications (10 Years): 4

Guangzhou Institutes of Biomedicine and Health (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Guangzhou Institutes of Biomedicine and Health Sep 01 2019

China

PHD

Publications

Zhiwu Jiang, Rui Liao, Jiang Lv, Shanglin Li, Diwei Zheng, Le Qin, Di Wu, Suimin Chen, Youguo Long, Qiting Wu, Suna Wang, Simiao Lin, Xiaohan Huang, Zhaoyang Tang, Pengcheng Shi, Hongsheng Zhou, Qi-Fa Liu, Ruocong Zhao, Yangqiu Li, Yang Jie, Wei Wei, Peilong Lai, Xin Du, Shuzhong Cui, Robert Weinkove, Pentao Liu, Duan-Qing Pei, Yao Yao, Peng Li
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells. Leukemia 35 (5) (2020)
Di Wu, Jiang Lv, Ruocong Zhao, Zhiping Wu, Diwei Zheng, Jingxuan Shi, Simiao Lin, Suna Wang, Qiting Wu, Youguo Long, Jiang Lv, Yao Yao
PSCA is a target of chimeric antigen receptor T cells in gastric cancer. Biomarker research 8 (2020)
Le Qin, Ruocong Zhao, Dongmei Chen, Xinru Wei, Qiting Wu, Youguo Long, Zhiwu Jiang, Yangqiu Li, Haipeng Wu, Xuchao Zhang, Yilong Wu, Shuzhong Cui, Wei Wei, Huihui Yao, Zixia Liu, Su Cao, Yao Yao, Zhenfeng Zhang, Jiang Lv
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth. Biomarker research 8 (2020)
Jiang Lv, Jiang Lv
Mesothelin as a biomarker for targeted therapy. Biomarker research 7 (2019)

Jiang Lv.css-eqlu8i{font-size:small;padding-left:4px;} (Peng Li)